LFCR
Lifecore Biomedical Inc.
4.40$
-2.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
Lifecore Biomedical Inc. (LFCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Operating Cash Flow" came in at 13 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.6 | -5.5 | -3.4 | -3.6 | 5.0 | -7.6 | -0.1 | 7.9 | 13 | 11 | -2.1 | 18 | 9.4 | 7.5 | 14 | 22 | 21 | 21 | 26 | 22 | 29 | 20 | 16 | -17 | 16 | -24 | -23 | 0.3 | -0.2 | 13 | |
| 0.5 | 1.1 | 2.1 | 2.2 | 6.1 | 5.4 | 3.5 | 3.7 | 3.5 | 3.2 | 3.3 | 3.2 | 3.1 | 3.4 | 5.3 | 5.6 | 7.3 | 7.1 | 7.1 | 9.4 | 11 | 12 | 15 | 19 | 20 | 18 | 18 | 8.0 | 8.0 | 6.8 | |
| – | – | – | – | – | – | – | – | – | – | – | -0.3 | 0.9 | 1.0 | 2.0 | 1.9 | 1.7 | 1.4 | 1.6 | 3.5 | 4.0 | 4.4 | 3.6 | 0.0 | 3.4 | 2.6 | 2.6 | 6.2 | 10 | 6.2 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.0 | 30 | 19 | 62 | 32 | – | – | – | |
| -0.1 | -1.0 | -2.4 | -3.0 | -0.1 | -5.7 | -4.3 | 0.7 | 3.6 | -0.1 | -11 | 0.8 | -2.8 | -4.3 | -2.9 | 8.2 | -4.0 | -0.8 | 3.3 | -2.5 | 0.6 | -10 | -1.2 | -28 | 9.8 | -6.6 | -3.1 | -3.7 | -4.7 | -2.3 | |
| 0.4 | 1.3 | 4.5 | 4.1 | 5.3 | 7.0 | 2.5 | 3.4 | 3.7 | 4.7 | 6.8 | 4.2 | 4.6 | 45 | 6.7 | 5.4 | 8.9 | 15 | 18 | 41 | 23 | 34 | 45 | 27 | 25 | 28 | 30 | 18 | 13 | 6.3 | |
| -21 | 5.7 | 4.1 | -3.1 | -16 | -4.0 | 7.5 | -1.4 | -5.2 | -5.5 | 42 | -20 | -12 | -43 | -29 | -44 | -10 | -13 | -34 | -42 | -25 | -36 | -97 | -24 | -12 | 82 | 80 | -18 | -6.4 | -1.6 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 45 | – | – | – | – | – | – | 0.7 | 0.2 | – | – | 0.3 | 3.1 | – | – | |
| – | – | – | – | – | – | – | – | – | – | -7.4 | -19 | – | – | -1.2 | -5.0 | 0.0 | -1.3 | -0.3 | – | -0.4 | -1.5 | -0.7 | -0.2 | -0.4 | – | -0.8 | -0.2 | – | -1.9 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 80 | 42 | 7.5 | -55 | 19 | 2.2 | -16 | – | |
| 35 | -9.2 | 3.3 | 0.7 | 17 | 12 | -8.3 | -3.8 | -1.4 | 2.3 | 2.1 | -15 | 2.0 | 20 | -4.8 | 36 | -19 | -7.2 | 8.2 | 16 | -8.8 | 13 | 79 | 40 | -3.4 | -57 | -57 | 7.5 | 6.4 | -1.1 | |
| 11 | -9.0 | 4.0 | -6.0 | 6.4 | 0.1 | -0.8 | 2.8 | 6.4 | 7.6 | 42 | -18 | -0.9 | -16 | -20 | 14 | -8.5 | 0.5 | -0.1 | -4.2 | -4.5 | -2.5 | -1.8 | -0.9 | 0.7 | 0.3 | 0.3 | -11 | -0.2 | -0.2 | |
| -4.0 | -6.8 | -7.9 | -7.7 | -0.3 | -15 | -2.6 | 4.5 | 9.4 | 6.1 | -8.8 | 13 | 4.9 | -37 | 7.8 | 17 | 12 | 6.2 | 8.6 | -19 | 6.7 | -14 | -29 | -44 | -8.8 | -53 | -53 | -18 | -14 | 6.2 |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.